Advancing Clinical Research Through Community Partnership: A Conversation with Dr. Susanna Naggie
Dr. Naggie highlights why strong community relationships are essential to clinical trials and translational science. She shares the value of building trust and increasing access to ensure research reflects the needs of the people it aims to serve.
Study suggests how to predict which cancer patients will benefit from ATR inhibitors
A study from cancer biologists at Duke University School of Medicine suggests a new way to predict which patients are most likely to benefit from a promising class of experimental cancer
Study reveals the brain work behind every bite
When you lift food to your mouth, your brain syncs movements of
hands, arms, lips, tongue and jaw. Scientists now say they’ve identified the brain circuitry that makes that everyday act possible. In a new study in mice, a team led by Josh Huang, PhD, identified a previously unknown motor cortex region that synchronizes hand and mouth movements during feeding. Activating the area triggered lifelike eating motions. Shutting parts of it down disrupted the behavior. The work could help explain how complex actions break down in conditions such as stroke or Parkinson’s disease.
ARLG takes aim at antibiotic resistance on global stage
The Antibacterial Resistance Leadership Group (ARLG), based at the Duke Clinical Research In
Duke and UNC researchers to co-lead $12.9M study to improve care for autistic children
Duke University has been awarded $12.9 million from the Patient-Centered Outcomes Research Institute (PCORI) for a new clinical trial aimed at improving the standard of care for autistic children with chronic digestive discomfort. The study will be co-led by researchers at UNC-Chapel Hill, underscoring the impact of the partnership between Duke Health and UNC Health to form North Carolina Children’s, which is planning to break ground in 2027.
Durham students commit early to health care careers at Duke
Over 100 students in Durham County enrolled last week in the incoming freshman class at the Durham Early College of Health Sciences. The school, an innovative partnership among Durham Public Schools, Durham Tech, and Duke Health, supported by a $29.5 million grant from Bloomberg Philanthropies, educates high school students in skill that lead to jobs in patient care or clinical research at Duke Health upon graduation.
Hidden enzyme may explain muscle loss tied to cancer treatment
Team from Duke University School of Medicine and Duke NUS identify an enzyme that helps explain why muscles weaken in some cancer patients.
A Rare Childhood Disease Finally Mapped
Duke Children's Hospital pinpoints genetic cause and disease course of alternating hemiplegia of childhood, a rare pediatric neurological disorder.
Catching a fungal enzyme open for business
Serious fungal infections are becoming more common and harder to treat as fungi develop resistance to drugs. A new Duke University study reveals, for the first time, how the antifungal drug caspofungin really works: instead of simply sticking to a fungal enzyme, it jams the process while the fungus is actively building its cell wall. Understanding this hidden mechanism helps explain why the drug sometimes fails and could lead to better antifungal treatments in the future.